| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |